2024
Enhancing the utility of chromosome 6 and 8 testing in uveal melanoma biopsies
MATUŠKOVÁ, Veronika, Pavla HORŇÁČKOVÁ, Marek MICHALEC, Lenka ZLÁMALÍKOVÁ, Květoslava MATULOVÁ et. al.Základní údaje
Originální název
Enhancing the utility of chromosome 6 and 8 testing in uveal melanoma biopsies
Autoři
MATUŠKOVÁ, Veronika, Pavla HORŇÁČKOVÁ, Marek MICHALEC, Lenka ZLÁMALÍKOVÁ, Květoslava MATULOVÁ a Michal UHER
Vydání
Biomedical Papers, OLOMOUC, PALACKY UNIV, MEDICAL FAC, 2024, 1213-8118
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 0.900 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001238711300001
Klíčová slova anglicky
uveal melanoma; chromosome 6; chromosome 8; CISH, FISH; progression free survival
Změněno: 2. 7. 2024 09:45, Mgr. Tereza Miškechová
Anotace
V originále
Background: The aim of this study was to evaluate the significance of testing the gain of chromosome 8 and the gain of chromosome 6 as prognostic markers in histopathological samples of enucleated eyes in with uveal melanoma. Methods: This is a retrospective study of 54 enucleated eyes. The status of chromosomes 3, 8 and 6 was tested by CISH, and FISH was used in a few samples. A follow-up for the detection of metastases was conducted in all patients. The statistical significance of chromosomal abnormalities as a prognostic factor for the development of metastases was determined. Results: The study group consists of 54 patients (average age 63 years), 28 men (51.9%) Monosomy 3 together with gain of chromosome 8 was found in 10 samples (18.5%). Both chromosomal abnormalities were detected in 6 (11%) patients. No chromosomal abnormality in 3 or 8 was detected in 21 (38.9%) patients. Abnormalities of chromosome 6 were present in 6 (11%) patients. Progression free survival after 5 years was 33.3% (95% CI 0.0; 83.3) in these patients. Conclusions: Our findings indicate a correlation between progression-free survival and the presence of changes in chromosome 3 and e 8 in uveal melanomas. The results underline the necessity of testing for both chromosomal aberrations.